Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Gynecology & Clinical Practices Volume 3 (2016), Article ID 3:IJGCP-124, 4 pages
http://dx.doi.org/10.15344/2394-4986/2016/124
Review Article
En Bloc Resection as a Potential Survival Factor for Surgical Treatment of Patients with Advanced Ovarian Cancer

Mall Eltermaa1, Khalid El Khalfaoui2, Adetutu Salau1, Zaher Halwani1*

1Department of Obstetrics and Gynecology, Vivantes Humboldt Klinikum, Berlin, Germany
2Department of Obstetrics and Gynecology, Evangelical Hospital Oberhausen (EKO), Oberhausen, Germany
Dr. Zaher Halwani, Department of Obstetrics and Gynecology, Vivantes Humboldt Klinikum, Berlin, Germany, Tel: (030)130- 121261; E-mail: tferzandi@tuftsmedicalcenter.org
24 May 2016; 08 November 2016; 10 November 2016
Eltermaa M, Khalfaoui KE, Salau A, Halwani Z (2016) En Bloc Resection as a Potential Survival Factor for Surgical Treatment of Patients with Advanced Ovarian Cancer. Int J Gynecol Clin Pract 3: 124. doi: http://dx.doi.org/10.15344/2394-4986/2016/124
© 2016 Eltermaa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Cancer Research UK
  2. Berek JS, Crum C, Friedlander M (2015) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 131 Suppl 2: S111-122 [CrossRef] [PubMed]
  3. SEER Cancer Statustics Factsheets: Ovary Cancer. National Cancer Institute, Bethesda
  4. Meigs JV (1934) Tumors of the female pelvic organs. New York: The Macmillan Company, USA, 533 p
  5. Kim A, Ueda Y, Naka T, Enomoto T (2012) Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 31: 14 [CrossRef] [Google Scholar] [PubMed]
  6. Chang SJ, Bristow RE (2012) Evolution of surgical treatment paradigms for advancedstage ovarian cancer: Redefining `optimal` residual disease. Gynecol Oncol 125: 483-492 [CrossRef] [Google Scholar] [PubMed]
  7. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, et al. (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97: 560-566 [CrossRef] [Google Scholar] [PubMed]
  8. Sehouli J (2012) Multimodales Management des Ovarialkarzinoms. (2. Auflage), Bremen: UNI-MED, Germany, 224 p
  9. Abu-Rustum NR, Barakat RR, Levine DA (2013) Atlas of Procedures in Gynecologic Oncology. (3rd edition) Florida: CRC Press, USA, 472 p
  10. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, et al. (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 115: 1234-1244 [CrossRef] [Google Scholar] [PubMed]
  11. Wharton JT, Edwards CL (1983) The role of surgery in the management of gynecologic malignancies. Cancer 51: 2480-2484 [CrossRef] [Google Scholar] [PubMed]
  12. Kroneman H, Castelein A, Jeekel J (1991) En bloc resection of colon carcinoma adherent to other organs: an efficacious treatment? Dis Colon Rectum 34: 780-783 [CrossRef] [Google Scholar] [PubMed]
  13. Hunter JA, Ryan JA Jr, Schultz P (1987) En bloc resection of colon cancer adherent to other organs. Am J Surg 154: 67-71 [CrossRef] [Google Scholar] [PubMed]
  14. Martin RC, Jaques DP, Brennan MF, Karpeh M (2002) Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg 194: 568-577 [CrossRef] [Google Scholar] [PubMed]
  15. Choi YY, Noh SH1,2, Cheong JH2,3, et al. (2015) Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 56: 1177-1185 [CrossRef] [Google Scholar] [PubMed]
  16. Baumann M (ed) (2016) Oxford Textbook of Oncology. (3rd edition), Oxford: Oxford University Press, UK, 832 p
  17. Cata JP, GottumukkalaV (2012) Blood Loss and Massive Transfusion in Patients Undergoing Major Oncological Surgery: What Do We Know? ISRN Anesthesiology 2012 [CrossRef] [Google Scholar]
  18. Ørskov M, Iachina M, Guldberg R, Mogensen O, Mertz Nørgård B (2016) Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study. BMJ Open 6: e010123 [CrossRef] [Google Scholar]
  19. Fourcadier E, Trétarre B, Gras-Aygon C, Ecarnot F, Daurès JP, et al. (2015) Under-treatment of elderly patients with ovarian cancer: a population based study. BMC Cancer 15: 937 [CrossRef] [Google Scholar] [PubMed]
  20. Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, et al. (2005) Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 99: 608-614 [CrossRef] [Google Scholar] [PubMed]
  21. Harter P, Muallem ZM, Buhrmann C, Lorenz D, Kaub C, et al. (2011) Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer. Gynecol Oncol 121: 615-619 [CrossRef] [Google Scholar] [PubMed]
  22. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, et al. (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107: 77-85 [CrossRef] [Google Scholar] [PubMed]
  23. du Bois A, Rochon J, Pfisterer J, Hoskins WJ (2009) Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 112: 422- 36 [CrossRef] [Google Scholar] [PubMed]
  24. Yildirim Y, Ertas IE, Nayki U, Ulug P, Nayki C, et al. (2014) En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer. Eur J Gynaecol Oncol 35: 400-407 [Google Scholar] [PubMed]
  25. Park JY, Seo SS, Kang S, Lee KB, Lim SY, et al. (2006) The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol 103: 977-984 [CrossRef] [Google Scholar] [PubMed]
  26. Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, et al. (2005) Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 99: 608-614 [CrossRef] [Google Scholar] [PubMed]
  27. Bridges JE, Leung Y, Hammond IG, McCartney AJ (1993) En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer 3: 199-202 [CrossRef] [Google Scholar] [PubMed]
  28. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, et al. (2001) Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 83: 115-120 [CrossRef] [Google Scholar] [PubMed]
  29. Benedetti-Panici P, Maneschi F, Scambia G, Cutillo G, Greggi S, et al. (1996) The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma. Obstet Gynecol 87: 532-538 [CrossRef] [Google Scholar] [PubMed]
  30. Markman M (2007) Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brif critique and a call for action. J Clin Oncol 25: 4168- 4170 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.